Canada markets closed

U.S. Stem Cell, Inc. (USRM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 03:42PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
82.049
82.049
200.749
277.087
Cost of Revenue
23.767
23.767
52.03
64.117
Gross Profit
58.282
58.282
148.719
212.97
Operating Expenses
Research Development
-
-
-
0
Selling General and Administrative
1,779
1,779
2,285
2,613
Total Operating Expenses
1,779
1,779
2,285
2,613
Operating Income or Loss
-1,720
-1,720
-2,136
-2,400
Interest Expense
689.977
689.977
1,000
488.369
Total Other Income/Expenses Net
-447.482
-447.482
-151.41
-1.883
Income Before Tax
-2,858
-2,858
-3,287
-2,890
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-2,858
-2,858
-3,287
-2,890
Net Income
-2,858
-2,858
-3,287
-2,890
Net Income available to common shareholders
-2,858
-2,858
-3,287
-2,890
Basic EPS
-0.00
-
-0.01
-0.01
Diluted EPS
-0.00
-
-0.01
-0.01
Basic Average Shares
555,618
-
460,794
429,291
Diluted Average Shares
555,618
-
460,794
429,291